Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02234180
Title Study of Adjuvant Regorafenib vs Placebo in Patients With Node Positive Esophageal Cancer That Completed Pre-operative Therapy
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Carle Cancer Center Urbana Illinois 61801 United States Details
Cancer Center of Kansas - Wichita Wichita Kansas 67214 United States Details
Ochsner Medical Center Jefferson New Orleans Louisiana 70121 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Missouri Valley Cancer Consortium Omaha Nebraska 68106 United States Details
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 United States Details
Memorial Sloan-Kettering Cancer Center New York New York 10065 United States Details
Comprehensive Cancer Center of Wake Forest University Winston-Salem North Carolina 27157 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Toledo Clinic Cancer Centers-Toledo Toledo Ohio 43623 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field